Viatris

Viatris VTRS Stock

$19.63   -1.257545%
Add to favorites
Market Cap
$22.50B
LOW - HIGH [24H]
$19.43 - $20.09
VOLUME [24H]
$9.27M
P/E Ratio
0
Earnings per share
-$0.53
ISIN
US92556V1061
Price   Prediction

Viatris Price Chart

Sorry, that's all we've gotfor now...

Viatris (VTRS) stock price today is 19.63 USD on Tech Market Large (-1.26% on the day). Updated .

Viatris VTRS Financial and Trading Overview

Viatris stock price 19.63 USD
Previous Close 19.88 USD
Open 19.99 USD
Bid 19.56 USD x 100
Ask 21.04 USD x 200
Day's Range 19.43 - 20.1 USD
52 Week Range 10.15 - 21.2 USD
Volume 9.27M USD
Avg. Volume 9.07M USD
Market Cap 22.5B USD
Beta (5Y Monthly) 0.871
PE Ratio (TTM) N/A
EPS (TTM) -0.53 USD
Forward Dividend & Yield 0.48 (2.41%)
Ex-Dividend Date November 23, 2026
1y Target Est 21.6 USD

VTRS Valuation Measures

Enterprise Value 34.36B USD
Trailing P/E N/A
Forward P/E 6.939804
PEG Ratio (5 yr expected) 3.61
Price/Sales (ttm) 1.5281496
Price/Book (mrq) 1.6444666
Enterprise Value/Revenue 2.333
Enterprise Value/EBITDA 7.852

Trading Information

Viatris Stock Price History

Beta (5Y Monthly) 0.871
52-Week Change 90.05%
S&P500 52-Week Change 8.67%
52 Week High 21.2 USD
52 Week Low 10.15 USD
50-Day Moving Average 18.41 USD
200-Day Moving Average 16.37 USD

VTRS Share Statistics

Avg. Volume (3 month) 9.07M USD
Avg. Daily Volume (10-Days) 11.66M USD
Shares Outstanding 1.15B
Float 1.14B
Short Ratio 4.02
% Held by Insiders 0.31%
% Held by Institutions 92.82%
Shares Short 35.24M
Short % of Float 3.08%
Short % of Shares Outstanding 3.07%

Dividends & Splits

Trailing Annual Dividend Rate 0.48
Trailing Annual Dividend Yield 2.41%
5 Year Average Dividend Yield 397.00%
Payout Ratio 9.6
Last Split Factor 3:2

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -4.12%
Operating Margin (ttm) 11.48%
Gross Margin 41.13%
EBITDA Margin 29.71%

Management Effectiveness

Return on Assets (ttm) 2.91%
Return on Equity (ttm) -4.20%

Income Statement

Revenue (ttm) 14.73B USD
Revenue Per Share (ttm) 12.75 USD
Quarterly Revenue Growth (yoy) -0.29%
Gross Profit (ttm) 6.06B USD
EBITDA 4.38B USD
Net Income Avi to Common (ttm) -607800000 USD
Diluted EPS (ttm) -0.53
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 2.01B USD
Total Cash Per Share (mrq) 1.75 USD
Total Debt (mrq) 13.58B USD
Total Debt/Equity (mrq) 99.22 USD
Current Ratio (mrq) 1.552
Book Value Per Share (mrq) 11.937

Cash Flow Statement

Operating Cash Flow (ttm) 2.49B USD
Levered Free Cash Flow (ttm) 3.16B USD

Profile of Viatris

Country United States
State PA
City Canonsburg
Address Robert J. Coury Global Center
ZIP 15317
Phone 724 514 1800
Website https://www.viatris.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 30000

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Q&A For Viatris Stock

What is a current VTRS stock price?

Viatris VTRS stock price today per share is 19.63 USD.

How to purchase Viatris stock?

You can buy VTRS shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Viatris?

The stock symbol or ticker of Viatris is VTRS.

Which industry does the Viatris company belong to?

The Viatris industry is Drug Manufacturers - Specialty & Generic.

How many shares does Viatris have in circulation?

The max supply of Viatris shares is 1.15B.

What is Viatris Price to Earnings Ratio (PE Ratio)?

Viatris PE Ratio is now.

What was Viatris earnings per share over the trailing 12 months (TTM)?

Viatris EPS is -0.53 USD over the trailing 12 months.

Which sector does the Viatris company belong to?

The Viatris sector is Healthcare.

Viatris VTRS included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 22617.73 USD —
-5.28
10.6B USD — 22513.01 USD — 23837.76 USD — — 10.6B USD —
us S&P 500 (Yahoo.com) GSPC US 6910.39 USD —
-3.7
4.73B USD — 6882.66 USD — 7198.67 USD — — 4.73B USD —
us S&P 500 INDEX SPX US 6910.39 USD —
-3.7
505.58M USD — 6882.66 USD — 7198.67 USD — — 505.58M USD —
us US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD US 2100.38 AUD 1467.26 USD
<0.01
— — 2100.38 AUD 1467.26 USD 2100.38 AUD 1467.26 USD — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
us US Tech US Smart Pharmaceuticals NQSSPH US 2214.31 USD —
-0.8
— — 2209.33 USD — 2262.42 USD — — — —
us US Tech Factor Family US Value I NQFFUSV US 2227.09 USD —
-0.94
— — 2223.03 USD — 2280.22 USD — — — —
us US Tech Next Generation 100 Inde NGX US 1607.36 USD —
-3.42
— — 1601.83 USD — 1668.4 USD — — — —
us US Tech Biotechnology NBI US 6781.89 USD —
-1.73
— — 6767.31 USD — 6980.47 USD — — — —
us US Tech Health Care IXHC US 1282.67 USD —
-1.79
— — 1279.99 USD — 1317.94 USD — — — —
us Dorsey Wright Momentum Plus Div DWAMY US 1673.16 USD —
-1.67
— — 1669.87 USD — 1715.16 USD — — — —
us US Tech Q-50 NXTQ US 1123.95 USD —
-3.25
— — 1119.74 USD — 1168.27 USD — — — —
us US Tech Global Select Market Com NQGS US 11139.01 USD —
-5.31
— — 11086.73 USD — 11742.47 USD — — — —
$2.09T
Total marketcap
$111.4B
Total volume
BTC 57.91%   •   ETH 9.84%
Dominance
Select currency